Oramed Pharmaceuticals Inc. Common Stock (ORMP) Stock
Fundamentals
Source: third-party data provider, as of October 12, 2026
Compare with ORMP
Recent news

LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years
LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years
ORMP

Best Penny Stocks To Buy Today? 4 To Watch Under $5
Best Penny Stocks To Buy Today? 4 To Watch Under $5
ORMP
Technical indicators
- RSI 14
- 38.16
- MACD 12/26/9
- -0.10
- EMA 9 of MACD
- -0.05
- MACD histogram
- -0.05
- SMA 50
- $4.65
- Price below SMA 50
- EMA 50
- $4.57
- Price below EMA 50
- SMA 200
- $3.96
- Price above SMA 200
- EMA 200
- $3.91
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
Source: third-party data provider
Latest news

LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years
LFWD Stock Sinks To Record Low On Second Reverse Split In Two Years
ORMP

Best Penny Stocks To Buy Today? 4 To Watch Under $5
Best Penny Stocks To Buy Today? 4 To Watch Under $5
ORMP
About Oramed Pharmaceuticals Inc. Common Stock
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Nadav Kidron Esq. | President, CEO & Executive Chairman | 1974 |
| Mr. Joshua Hexter | Chief Operating & Business Officer | 1970 |
| Dr. Miriam Kidron Ph.D. | Chief Scientific Officer & Director | 1940 |
| Mr. Avraham Gabay | CFO, Treasurer & Secretary | 1985 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 12, 2026
Technical indicators
- RSI 14
- 38.16
- MACD 12/26/9
- -0.10
- EMA 9 of MACD
- -0.05
- MACD histogram
- -0.05
- SMA 50
- $4.65
- Price below SMA 50
- EMA 50
- $4.57
- Price below EMA 50
- SMA 200
- $3.96
- Price above SMA 200
- EMA 200
- $3.91
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.0 | -11.7 | +14.4 | -3.7 | -3.3 |



